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Abstract
Objective: Staphylococcus aureus is a major human pathogen, and nasal carriers have an increased risk for infection 
and disease. The exploration of host determinants for nasal carriage is relevant to decrease infection burden. Former 
studies demonstrate lower carriage prevalence in women and among users of progestin-only contraceptives. The aim 
of this study was to investigate the possible associations between circulating sex-steroid hormones and nasal carriage 
of Staphylococcus aureus in a general population.
Methods: In the population-based sixth Tromsø study (2007–2008) nurses collected nasal swab samples from 724 
women aged 30–87 not using any exogenous hormones, and 700 of the women had a repeated nasal swab taken 
(median interval 28 days). We analysed a panel of serum sex-steroids by liquid chromatography tandem mass 
spectrometry, and collected information about lifestyle, health and anthropometric measures. Multivariable logistic 
regression was used to study the association between circulating sex-steroids and Staphylococcus aureus carriage (one 
swab) and persistent carriage (two swabs), while adjusting for potential confounding factors. Women in luteal phase 
were excluded in the analysis of androgens.
Results: Staphylococcus aureus persistent nasal carriage prevalence was 22%. One standard deviation increase in 
testosterone and bioavailable testosterone was associated with lower odds of persistent nasal carriage, (OR = 0.57; 
95% CI = 0.35–0.92 and OR = 0.52, 95% CI = 0.30–0.92) respectively. Analysis stratified by menopause gave similar 
findings. Persistent carriers had lower average levels of androstenedione and DHEA, however, not statistically 
significant.
Conclusion: This large population-based study supports that women with lower levels of circulating testosterone may 
have increased probability of Staphylococcus aureus persistent carriage.
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Staphylococcus aureus is the leading cause of skin and soft 
tissue infections, and can invade and infect any organ of 
the human body. S. aureus is the second most common 
cause of bloodstream infections (1), which continue to 
have high mortality among patients worldwide (2, 3). 
The burden of disease and mortality reflect S. aureus’ 
extraordinary virulence factors, including highly evolved 
immune evasion strategies and resistance to antibiotic 
treatment (4).
S. aureus is frequent in the normal bacterial flora of 
healthy humans, and 20–50% of the population are nasal 
carriers (4, 5, 6, 7). Colonisation of the skin in the anterior 
nares is a major source of endogenous S. aureus infections 
and transmission (4). This motivates the search for lifestyle 
and environmental factors and associated biomarkers 
that may regulate immune responses to S. aureus. Among 
populations from different continents, male sex, younger 
age, atopic eczema, excess body weight, higher circulating 
glucose levels and diabetes, lower vitamin D levels, and 
work in health care services have been associated with 
higher probability of S. aureus nasal carriage, while 
smoking has been associated with both lower and higher 
probability of carriage (4, 5, 8, 9, 10, 11, 12, 13).
Sex-steroids are produced from cholesterol in testes 
or ovaries and the adrenal glands, and may be further 
converted to more potent sex-steroids in fat and other 
tissue. Sex-differences in immunological responses are 
largely caused by sex-steroid hormone actions, through 
binding to nuclear receptors and regulation of immune 
system genes expression in a variety of cells (14). In 
general, adult women have a more responsive immune 
system with faster clearance of pathogens and greater 
vaccine efficacy compared to men but are more prone to 
inflammatory and autoimmune diseases. Sex and age are 
the strongest risk factors for S. aureus nasal carriage (4, 8, 9). 
Thus, it has been hypothesised that sex-steroid hormones 
are important in the immune response to S. aureus. Smaller 
studies among women have found a positive association 
of nasal S. aureus carriage with biomarkers of endogenous 
oestrogen level (15), as well as of nasal S. aureus carriage 
with exogenous oestrogen and progesterone (i.e. hormonal 
contraceptive combination preparations) (16, 17). One 
small study among premenopausal women found higher 
prevalence of persistent throat carriage of S. aureus with 
increasing levels of free fraction testosterone (18). From 
the population-based sixth Tromsø study (2007–2008), 
we reported higher nasal carriage among men and sex-
differences in the distribution of S. aureus spa types 
(genetic variance by S. aureus protein A (spa) typing) (9). 
Among 400 young women in the Tromsø study fit futures 
(2012–2013), where 50% used hormonal contraception, 
we found a positive dose-response relationship between 
oestrogen dose and S. aureus nasal carriage, and a negative 
association between exogenous progesterone alone and 
nasal carriage (17). To our knowledge, no epidemiological 
study has examined whether endogenous sex-hormone 
levels are associated with S. aureus nasal carriage among 
women. Thus, the aim of this study is to investigate the 
possible associations between circulating sex-steroid 
hormones and nasal carriage of S. aureus in a general 
female population.
Methods
Population and study design
The Tromsø study includes seven extensive health-
screening surveys in the Tromsø municipality, North 
Norway, during 1974–2016 with invitation of total birth 
cohorts and large random samples of the population (5, 
11). Each of these surveys consists of clinical examinations 
including anthropometric measures, non-fasting blood 
samples, interview covering menstrual history and 
hormonal medication, questionnaires on reproductive 
history, lifestyle, health and chronic disease (5, 11, 12). 
The present study uses data from the sixth Tromsø study 
(the sixth Tromsø study, participation proportion 66%).
Body height in centimetres (cm) and weight in 
kilograms (kg) were measured to the nearest 0.1 unit 
with participants wearing light clothing and no shoes. 
BMI was calculated as weight divided by height squared 
(kg/m2). Non-fasting blood samples were drawn from an 
antecubital vein. Glycated haemoglobin (HbA1c) was 
determined in EDTA-blood by HPLC using an automated 
analyser (Variant II, Bio-Rad Laboratories Inc.). The total 
analytical coefficient of variation was <3.0%. Serum 
25-hydroxyvitamin D (25(OH)D) was analysed by 
electrochemiluminescence immunoassay (ECLIA) using 
an automated clinical chemistry analyser (Modular E170, 
Roche Diagnostics). The total analytical coefficient of 
variation was 7.3%. There is a known overestimation of 
25(OH)D levels in smokers when using the ECLIA (Roche) 
method (19). This necessitates stratification by smoking 
in the statistical analysis of 25(OH)D.
Nasal swabs for S. aureus culturing were collected 
from a random sample of 4026 participants attending 
the sixth Tromsø study screening centre during October 
2007 to June 2008, 2285 of these were women. All women 
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without data on serum hormones, participants reporting 
antibiotic use or missing data on antibiotic use the last 24 
h, ongoing pregnancy, use of hormonal contraceptives, 
use of hormonal replacement therapy, endocrine breast 
cancer therapy and IVF treatment were excluded from the 
analysis. The participants were invited to a second visit 
for repeated nasal swab sampling. Women with invalid or 
missing S. aureus culturing results were excluded from the 
analysis (Fig. 1).
Assessment of S. aureus carriage and 
serum sex-steroids
Nurses at the sixth Tromsø study screening centre collected 
nasal swab samples. Each nasal vestibule was sampled 
with the same NaCl (0.9%)-moistened sterile rayon-tipped 
swab which was rotated three times. The swabs were 
immediately placed in transport medium (Amies Copan, 
Brescia, Italy) and stored at 4°C for a maximum of 3 days. 
Trained personnel at the Department of Microbiology and 
Infection Control, University Hospital of North Norway, 
(UNN) Tromsø analysed the microbiological samples. The 
specimens were cultured on blood agar (Oxoid, UK) for 
growth control and chromID-plates (SAID) for S. aureus 
detection (bioMérieux, Marcy I’Etoile, France). The agar 
plates were incubated for 42–48 h at 37°C. To retain 
high specificity, colony morphology was examined, and 
the most dominating colony type on the SAID plate was 
confirmed as S. aureus by the Staphaurex plus agglutination 
test (Murex Diagnostic Ltd, Dartford, UK). Growth of any 
bacterial colonies on agar plates was registered as a valid 
culture.
The median interval between the first and the second 
nasal swab culture was 28 days.
S. aureus nasal carriage status was classified according 
to baseline sample status. S. aureus persistent carriage was 
defined as having two positive samples on the basis of van 
Belkum’s definition of persistent carriage (20).
The Hormone laboratory at Haukeland University 
Hospital analysed a panel of serum sex-steroids by liquid 
chromatography tandem mass spectrometry (LCMS/MS, 
SCIEX API 5500 triple-quadrupole mass spectrometer, 
Applied Biosystems/MDS with an Agilent 1290 UPLC 
system), as part of the laboratory’s work on establishing 
reference values within subgroups of the general 
population (i.e. by sex, age, and BMI categories) 
(21). LCMS/MS is the gold standard method for 
steroid profiling due to very high sensitivity and 
specificity (22). Serum concentrations of testosterone, 
androstenedione, dehydroandrostenedione (DHEAS), 
17α-hydroxyprogesterone (17-OH progesterone), 
progesterone, luteinising hormone (LH), follicle-
stimulating hormone (FSH), as well as the binding proteins 
sex-hormone binding globulin (SHBG) and albumin 
were measured using DPC immulite 200 XPi (Siemens 
Healthcare Diagnostics). For the estimation of bioavailable 
testosterone which includes free and albumin-bound 
testosterone we used the equation ‘(testosterone/SHBG) 
× 10’ (23) and the equation derived by Morris et al. (24).
Classification of menopause and menstrual phase
To classify menopausal status, we used the following 
question from the interview: ‘Do you still have natural 
menstruation?‘ (yes/no/irregular/unknown status). We 
also defined FSH-level over 21.7 IU as postmenopausal 
and FSH-level under 21.7 IU as premenopausal (25, 26). 
Female participants reporting no menses with FSH-levels 
under 21.7 IU were further classified by the question from 
the interview: ‘If you do not have natural menstruation, 
why did it stop?‘ (stopped by itself/I had a hysterectomy/
both ovaries were removed/other reasons (for instance 
radiation, cytotoxic mediation)). FSH-levels can be 
difficult to interpret because of the possible high levels 
in perimenopause, we therefore emphasised self-reported 
menstruation in classification of menopause. FSH-levels 
were used to confirm clinical history and to classify 
females with no data on self-reported menses. Among 
women with unknown status on menstruation from 
Figure 1
The study population. The sixth Tromsø study.
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the interview, age was used as an additional criterium in 
those with FSH-levels above 21.7 IU (age ≥ 51 years were 
classified as postmenopausal). One female participant 
reported no menses but had information about recent 
menstruation, we therefore concluded that this probably 
were due to misreporting on menstruation and classified 
the participant by FSH levels (Fig. 2).
Premenopausal women were further classified as 
follicular phase or luteal phase according to progesterone 
levels. Follicular phase were defined as progesterone levels 
Figure 2
Classification of menstruation status, the sixth Tromsø study. ‘Do you have menstruation?’ corresponds with the interview 
question ‘Do you still have natural menstruation?’ *Participants reporting irregular menstruation (n = 2) are reclassified as ‘yes’. 
FSH in IU, age in years. A full colour version of this figure is available at https ://do i.org /10.1 530/E JE-20 -0877 .
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≤5.5 nmol/L and luteal phase as progesterone levels >5.5 
nmol/L (27). In the analysis including premenopausal 
women, women in the luteal phase are excluded to 
increase accuracy of the testosterone measurement (28).
Statistical analysis
Statistical analysis was performed using Stata/MP 15.1 
for Macintosh. Univariable associations were analysed in 
contingency tables by calculating means and s.d. using chi-
square and t-test to quantify the potential role of chance. 
Independent samples t-test were used to test possible 
associations between sex-steroid hormones, carriage 
and persistent carriage. Multivariable logistic regression 
was fitted to estimate odds ratios (ORs) and 95% CIs to 
describe the associations between sex-steroid hormones 
and S. aureus nasal carriage and S. aureus persistent nasal 
carriage while adjusting for potential confounders. 
Missing values were excluded from the logistic regression 
analysis. DAGitty 3.0 was used for model selection (29). 
Testing for potential interaction between explanatory 
variables was done by including the multiplicative terms 
of two predictor variables in the model. P-values of ≤0.05 
were considered statistically significant.
Ethics
Each participant in the sixth Tromsø study signed a 
declaration of consent. The study does not include data 
from participants with their declaration of consent 
withdrawn after participation. Tromsø 6 was approved 
by the Regional Committee for Medical and Health 
Research Ethics (REK) and the Norwegian Data Protection 
Authority. The present analysis was approved by REK 
(2018/1975/REK nord).
Results
In this population of female participants with age 30–87 
years (mean = 53.5, s.d. = 13.6), the prevalence of S. 
aureus nasal carriage was 24% (180/724), and of S. aureus 
persistent nasal carriage 22% (151/700) (Table 1 and 
Supplementary Table 1, see section on supplementary 
materials given at the end of this article).
In postmenopausal women, mean level of testosterone 
were significantly lower in persistent nasal carriers 
compared to others (mean difference (MD) = 0.10 95% 
CI = 0.00–0.20) (Table 2). When postmenopausal women’s 
carrier state was assessed from only one nasal swab, the 
mean level of bioavailable testosterone was 0.15 nmol/L 
for non-carriers and 0.13 nmol/L for carriers (MD = 0.02 
95% CI = −0.00 to 0.04) (Supplementary Table 2). In 
postmenopausal women, serum levels of androstenedione, 
DHEAS, and 17α-hydroxyprogesterone were lower in nasal 
carriers than in others but not statistically significant 
(Table 2).
Using DAGitty (29), age and BMI were identified 
as sufficient covariates in the regression analysis when 
estimating the association between sex-steroids and S. 
aureus nasal carriage in women. In a multivariable logistic 
regression model adjusted for age and BMI, an increase of 
1 s.d. (s.d. = 0.81 nmol/L) of testosterone lowered the odds 
of nasal carriage of S. aureus (OR = 0.60; 95% CI = 0.39–
0.94) as well as persistent nasal carriage (OR = 0.57; 95% 
CI = 0.35–0.92; s.d. = 0.82 nmol/L) (Table 3).
When stratifying by menopausal status, this 
decrease in odds of persistent nasal carriage by higher 
testosterone was also found in postmenopausal women 
(OR = 0.74; 95% CI = 0.55–0.99; s.d. = 0.43 nmol/L). In 
premenopausal women, the association was similar but 
not statistically significant (OR = 0.35; 95% CI = 0.05–2.29; 
s.d. = 1.48 nmol/L). The odds of nasal carriage by higher 
Table 1 Characteristics of the study population by Staphylococcus aureus nasal carrier state. The sixth Tromsø study. Data are 
presented as mean ± S.D. or as n (%).
Carrier state, n = 724 Persistent carrier state, n = 700
Non-carrier Carrier P-valuea Othersb Persistent carrier P-valuea
n 544 180 549 151
Age, years 55.9 ± 13.4 55.1 ± 13.7 0.485 56.1 ± 13.3 56.7 ± 13.3 0.628
BMI, kg/m2 27.6 ± 5.2 28.2 ± 5.6 0.204 27.5 ± 5.1 28.4 ± 5.8 0.069
Menstruation phase
 Menopause 346 (63.6 %) 113 (62.8 %) 0.935 356 (64.9 %) 103 (68.2 %) 0.487
 Luteal phase 87 (16.0 %) 28 (15.5 %) 87 (15.8 %) 18 (11.9 %)
 Follicular phase 111 (20.4 %) 39 (21.7 %) 106 (19.3 %) 30 (19.9 %)
*Chi-square test for categorical and t-tests for continuous variables; bothers; Intermittent carriers (one positive nasal samples of two samples in total) n = 
49; non-carriers (two negative nasal samples of two samples in total) n = 500.
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testosterone were lower but not statistically significant 
for premenopausal women (OR = 0.30; 95% CI = 0.06–
1.56; s.d. = 1.41 nmol/L) and for postmenopausal women 
(OR = 0.78; 95% CI = 0.59–1.02; s.d. = 0.43 nmol/L).
Multivariable logistic regression analysis showed a 
lower odds of nasal carriage (OR = 0.53; 95% CI = 0.32–
0.90) and persistent nasal carriage (OR = 0.52; 95% 
CI = 0.30–0.92) for an increase in bioavailable testosterone 
by one standard deviation (s.d. = 0.19 nmol/L) (Table 3).
As for testosterone a decrease in odds of persistent 
nasal carriage was also found for postmenopausal women 
(OR = 0.72; 95% CI = 0.52–0.99; s.d. = 0.09 nmol/L). In 
premenopausal women, there was a similar association 
(OR = 0.38; 95% CI = 0.06–2.45; s.d. = 0.34 nmol/L). The 
odds of nasal carriage were lower but not statistically 
significant for premenopausal women (OR = 0.28; 95% 
CI = 0.05–1.46; s.d. = 0.34 nmol/L) and for postmenopausal 
women (OR = 0.75; 95% CI = 0.56–1.01; s.d. = 0.09 nmol/L).
There was an inverse dose-response relationship 
between bioavailable testosterone and S. aureus carriage 
and persistent carriage, as well as for testosterone. In this 
female population, 98% had serum testosterone levels 
between 0 and 2 nmol/L, the estimates for values over 2 
nmol/L are therefore more uncertain (Fig. 3).
Interaction analysis between all variables in the final 
model revealed no significant interactions. When the 
equation by Morris et al. was used to calculate bioavailable 
testosterone there was no change in the risk estimates 
for S. aureus carriage (Supplementary Table 5) (24). One 
female participant had an extreme value of testosterone 
(17.42 nmol/L, population-mean: 0.8 nmol/L). Estimates 
from the final model did not differ when including or 
excluding this observation, and the presented results 
therefore include this observation.
Discussion
In this large population-based study of women not using 
any exogenous hormones, we report novel evidence of 
the association between circulating testosterone and 
bioavailable testosterone and S. aureus nasal carriage 
in women. This is to our knowledge the first study of 
circulating sex-steroids and S. aureus nasal carriage in a 
general female population. With increasing testosterone 
by one standard deviation, we see a 40% decrease in odds 
of S. aureus nasal carriage and a 43% decrease in S. aureus 
Table 2 Mean difference and CI in circulating sex-steroids, gonadotropins and binding protein levels among Staphylococcus 
aureus persistent nasal carriers compared to others. The sixth Tromsø study.
Premenopausal, n = 237a,b Postmenopausal, n = 445a
Mean differencec 95% CId Mean differencec 95% CId
Testosterone, nmol/L 0.22 −0.38 to 0.83 0.10 0.00–0.20
Bioavailable testosteronee, nmol/L 0.04 −0.11 to 0.18 0.18 −0.00 to 0.04
Androstenedione, nmol/L 0.17 −0.42 to 0.76 0.12 −0.13 to 0.36
Dehydroepiandrosterone, nmol/L −0.04 −0.93 to 0.85 0.33 −0.04 to 0.69
17α-hydroxyprogesterone, nmol/L 0.88 −2.44 to 4.20 0.14 −0.18 to 0.46
Progesterone, nmol/L 1.57 −3.54 to 6.69 0.04 −0.04 to 0.11
Sex-hormone binding globulin, nmol/L 9.91 0.73–19.09 −0.89 −7.72 to 5.93
Albumin, nmol/L 0.05 −0.83 to 0.93 0.18 −0.42 to 0.78
Luteinising hormone, IU −0.26 −2.99 to 2.47 0.80 −1.67 to 3.26
Follicle-stimulating hormone, IU 2.68 −1.65 to 7.01 1.39 −4.43 to 7.21
aNumber may vary due to missing values; bwomen in luteal phase are excluded in the analysis of testosterone, bioavailable testosterone, 
androstenedione and DHEA; cmean difference = mean (others) – mean (persistent carriage); dindependent sample t-test; ebioavailable testosterone 
calculated from the equation ‘(testosterone/SHBG) × 10’.
Table 3 Associations between testosterone, bioavailable 
testosterone and Staphylococcus aureus nasal carriage and 
persistent carriage. Analysis on menopausal women and 
premenopausal women in follicular phase. Odds ratios (ORs) and 






 per s.d.a 0.60 (0.39–0.94) 0.57 (0.35–0.92)
 BMI, kg/m2 1.03 (0.99–1.07) 1.03 (0.99–1.07)
 Age, year 0.99 (0.98–1.01) 1.00 (0.98–1.02)
Bioavailable testosterone
 n 557 544
 per s.d.b,c 0.53 (0.32–0.90) 0.52 (0.30–0.92)
 BMI, kg/m2 1.05 (1.01–1.09) 1.06 (1.01–1.10)
 Age, year 0.99 (0.98–1.01) 1.00 (0.98–1.01)
aSerum testosterone (nmol/L) s.d.: analysis of nasal carriage, s.d. = 0.81; 
analysis of persistent nasal carriage, s.d. = 0.82; bbioavailable testosterone 
(nmol/L) s.d.: analysis of nasal carriage, s.d. = 0.19; analysis of persistent 
nasal carriage, s.d. = 0.19; cioavailable testosterone calculated from the 
equation: (testosterone/SHBG) × 10.
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persistent nasal carriage compared to non-carriers and 
others (at least one of two nasal swab cultures negative for 
S. aureus), respectively. The same inverse associations are 
present in analysis stratified by menopausal status (range 
of ORs from 0.30 to 0.78), but statistically significant 
only for persistent nasal carriage in postmenopausal 
women.
We report a lowering in odds of S. aureus nasal carriage 
and S. aureus persistent nasal carriage of 47 and 48%, 
respectively, with increase of bioavailable testosterone 
by one standard deviation compared to non-carriers and 
others. In postmenopausal women, the association with 
S. aureus persistent carriage was weaker, but statistically 
significant. All other estimates from analysis stratified by 
menopausal status show the same inverse associations 
between bioavailable testosterone and both nasal carriage 
and persistent nasal carriage, range of ORs from 0.28 
to 0.75, however, not statistically significant. Possibly, 
we lack the statistical power to identify a significant 
association because of the low number of participants in 
the subpopulations of premenopausal women (n = 135–
148). Persistent nasal carriers also had lower average levels 
of androstenedione and DHEAS, however not statistically 
significant.
The knowledge of host response during S. aureus 
nasal carriage is limited. The presence of S. aureus nasal 
carriage induces both innate and adaptive immune 
responses, but the bacteria overcome host defence 
mechanisms to establish carrier status (6, 30). Innate 
immunity exerts the first response against microbes, 
and the association between delayed response of toll-
like receptor 2 in mice and nasal carriage has been 
demonstrated (31). In animal models, hypogonadism 
is associated with an increase in immune response 
with castration of male mice increasing autoimmune 
encephalomyelitis severity (32) and the incidence and 
severity of thyroiditis and adjuvant arthritis in rats (33). 
A recent study demonstrated an immunomodulating role 
of dihydrotestosterone in both human and rat vaginal 
smooth muscle cells (34). In summary, studies in animals 
document a significant effect of sex-steroid hormones on 
the immune system, but the results from in vitro studies 
are conflicting (35). Testosterone has been characterised 
as immunosuppressive, but recent research suggests 
that testosterones immunomodulatory effects depend 
on the reproductive context and menopausal status. 
There are also inconsistency of results for testosterone 
in both postmenopausal and premenopausal women 
where testosterone has been characterised as both pro-
inflammatory and anti-inflammatory (36).
Former studies have shown a positive association 
between combination-hormonal contraceptives and 
S. aureus nasal carriage, but lower odds of carriage with 
progestin-only contraceptives. Studies have demonstrated 
lower levels of bioavailable testosterone in women using 
combined oral contraceptives (37). This supports the 
finding of lower odds of S. aureus nasal carriage in women 
with higher bioavailable testosterone. Progestin is a 
synthetic progestogen and is classified from its chemical 
structure as a derivate of testosterone or progesterone (38). 
Therefore, progestin has both androgen and progestogen 
activity when used in contraceptives, and progestin-only 
Figure 3
Probability of S. aureus nasal carriage (top) 
and persistent nasal carriage according to 
testosterone (left) and bioavailable 
testosterone (right). Analysis of 
postmenopausal women and 
premenopausal women in follicular phase. 
Testosterone and bioavailable 
testosterone per nmol/L. Bioavailable 
testosterone calculated from the equation 
‘(testosterone/SHBG) × 10‘. A full colour 
version of this figure is available at https ://
do i.org /10.1 530/E JE-20 -0877 .
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users may have a higher prevalence of androgenic side 
effects than combination-contraceptive users because of 
the lack of the oestrogen component (39).
High androgen and testosterone levels stimulate the 
sebaceous glands to increased sebum production, and 
plays an important role in the development of acne (40). 
In this study, 50–75% of women with polycystic ovary 
syndrome have high values of bioavailable testosterone 
and some of the diagnostic criteria are hyperandrogenistic 
features as acne (41). These hormonally related changes 
may also affect the microbiota of the skin and promote 
bacteria like Cutibacterium acnes that suppress the 
growth of other bacteria like S. aureus (42). This may be a 
plausible biological mechanism contributing to the lower 
probability of carriage of S. aureus with higher testosterone 
in our study.
Testosterone levels in women, as oestrogen levels, 
decline in the fourth decade of life and after menopause. 
Though the biological role of testosterone in women 
remains largely unclear, androgens are biological 
precursors of oestrogen production (43). High level of 
testosterone may therefore represent higher level of 
estrogen. However, oestrogen was not measured in our 
study. Estrogen has been theorised to have both pro-
inflammatory and anti-inflammatory effects (44). One 
study found high testosterone and estradiol, and low 
SHBG levels associated with conditions that represent 
low-grade inflammation processes (45). The lower odds of 
S. aureus carriage with high levels of testosterone may be 
an indirect effect of possibly corresponding high levels of 
oestrogen or the unknown ratio between testosterone and 
oestrogen.
The major circulating steroids classified as androgens 
include DHEAS, androstenedione and testosterone (46). 
The lower levels of DHEAS and androstenedione in S. 
aureus persistent nasal carriers among postmenopausal 
women support our findings of lower odds of S. aureus 
carriage with higher levels of bioavailable testosterone and 
testosterone (Supplementary Fig. 2). This may represent 
an unknown effect of androgens on the immune system 
and increases the validity of the main finding.
We found no statistically significant association 
between androstenedione, LH, FSH, DHEAS, 17-OH 
progesterone, progesterone, SHBG, albumin and S. aureus 
nasal carriage and persistent carriage. This may be due 
to more complex relationships between sex-steroid 
hormones and the immune system. For premenopausal 
women, the female sex-steroid hormones have cyclic 
variations and data based on one measurement may not 
be representative for the participants’ hormonal status.
It has been reported that the equation ‘(testosterone/
SHBG × 10)‘ is not a reliable when SHBG concentration is 
low (47). Our analysis does not differ when using either 
this equation or the equation by Morris et al. (24) for the 
calculation of bioavailable testosterone. This may be due 
to our study population with mostly healthy women 
with normal BMI that has a low prevalence of very low 
measurements of SHBG (48, 49).
We used DAGitty for model selection, and the 
recommended confounders to adjust for in the analysis 
were BMI, HbA1c and age (Supplementary Fig. 1). Because 
of the minor insignificant effect on the main analysis of 
HbA1c, we decided to only adjust for BMI and age. We 
report a significant decrease of S. aureus with smoking, 
and a significant association with alcohol use. Because 
of the decision of not doing model selection by data 
driven statistical selection process, we did not include 
these variables in the final logistic regression model 
(Supplementary Tables 3 and 4). We include tables in 
Supplementary information for the reader to explore 
the odds ratio estimates including different possible 
covariates. The odds ratio estimates changed only slightly 
in these models. Although our data do not support any 
interactions among the explanatory variables, we cannot 
rule out the presence of smaller interaction effects that 
can only be detected by larger sample sizes.
Strengths of our study include a population-based 
design with high attendance, and consequently reduced 
risk of selection bias. Trained nurses collected nasal swab 
samples, and analyses of blood samples were performed 
with current gold standard assays for analysing sex-steroid 
hormones. Using both medical history and circulating 
FSH-levels to classify premenopausal and menopausal 
women reduces misclassification bias. One possible bias 
in the study is misclassification of S. aureus carrier status 
due to only two nasal swab samples, as van Belkum et al. 
recommend seven samples to correctly classify persistent 
carriers from intermittent carriers. Intermittent carriers 
has a lower risk of infections similar to non-carriers as well 
as similar elimination kinetics (20). Thus, we may have an 
unknown number of intermittent carriers misclassified as 
persistent in our study, which may have biased the risk 
estimates towards the null. However, large population-
based data reduces the risk of selection bias and increases 
both the internal and external validity.
In conclusion, we report evidence of an association 
between circulating testosterone and bioavailable 
testosterone and S. aureus nasal carriage defined from 
both one and two swab samples in females. Higher levels 
of bioavailable testosterone are associated with lower 
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odds for S. aureus nasal carriage of 39–43%. The role of 
testosterone and bioavailable testosterone in S. aureus 
nasal carriage ought to be addressed in future prospective 
studies to identify risk groups for prevention of S. aureus 
carriage and disease.
Supplementary materials
This is linked to the online version of the paper at https ://do i.org /10.1 530/
E JE-20 -0877 .
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